Venous and arterial thrombotic events in systemic lupus erythematosus

Journal of Rheumatology

Volumn 43, Issue 3, 2016, Pages 576-586

  Hinojosa Azaola, Andrea ^a   Romero Diaz, Juanita ^a   Vargas Ruiz, Angel Gabriel ^a   Nuñez Alvarez, Carlos A ^a   Cicero Casarrubias, Alba ^a   Ocampo Torres, Mario C ^a   Sanchez Guerrero, Jorge ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Anti RNP Sm; Lupus anticoagulant; Systemic lupus erythematosus; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; LUPUS ANTICOAGULANT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RIBONUCLEOPROTEIN ANTIBODY; SM ANTIBODY;

ADOLESCENT; ADULT; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VEIN THROMBOSIS; ADVERSE EFFECTS; AGE; COMPLICATION; INCIDENCE; INTRACRANIAL ARTERIAL DISEASES; MIDDLE AGED; RISK FACTOR; THROMBOSIS; VENOUS THROMBOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; INTRACRANIAL ARTERIAL DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; THROMBOSIS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84959930689     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150506     Document Type: Article

References (36)

1. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7.
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003;82:299-308.
3. White RH. The epidemiology of venous thromboembolism. Circulation Suppl 2003;107 Suppl 1:I4-8.
4. Sarabi ZS, Chang E, Bobba R, Ibanez D, Gladman D, Urowitz M, et al. Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Rheum 2005;53:609-12.
5. Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 2005;52:2774-82.
6. Chang ER, Pineau CA, Bernatsky S, Neville C, Clarke AE, Fortin PR. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus. J Rheumatol 2006;33:1780-4.
7. Kaiser R, Cleveland CM, Criswell LA. Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis 2009;68:238-41.
8. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555-64.
9. Toloza SM, Uribe AG, McGwin G Jr, Alarcon GS, Fessler BJ, Bastian HM, et al; LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004;50:3947-57.
10. Calvo-Alen J, Toloza SM, Fernandez M, Bastian HM, Fessler BJ, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum 2005;52:2060-8.
11. Romero-Diaz J, Garcia-Sosa I, Sanchez-Guerrero J. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol 2009;36:68-75.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
14. Romero-Diaz J, Vargas-Vorackova F, Kimura-Hayama E, Cortazar-Benitez LF, Gijon-Mitre R, Criales S, et al. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology 2012;51:110-9.
15. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
16. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
17. Ibanez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol 2003;30:1977-82.
18. Aillaud MF, Pouymayou K, Brunet D, Parrot G, Alessi MC, Amiral J, et al. New direct assay of free protein S antigen applied to diagnosis of protein S deficiency. Thromb Haemost 1996;75:283-5.
19. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med 2002;126:1349-66.
20. Boyer-Neumann C, Bertina RM, Tripodi A, D'Angelo A, Wolf M, Vigano D'Angelo S, et al. Comparison of functional assays for protein S: European collaborative study of patients with congenital and acquired deficiency. Thromb Haemost 1993;70:946-50.
21. Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol 2010;85:440-2.
22. Vinazzer H, Pangraz U. Protein C: Comparison of different assays in normal and abnormal plasma samples. Thromb Res 1987;46:1-8.
23. Muszbek L, Bereczky Z, Kovacs B, Komaromi I. Antithrombin deficiency and its laboratory diagnosis. Clin Chem Lab Med 2010;48 Suppl 1:S67-78.
24. Rossi E, Mondonico P, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 1988;52:453-68.
25. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen]. [Article in German] Acta Haematol 1957;17:237-46.
26. Kershaw G, Suresh S, Orellana D, Nguy YM. Laboratory identification of lupus anticoagulants. Semin Thromb Hemost 2012;38:375-84.
27. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7:1737-40.
28. Ahluwalia J, Sreedharanunni S, Kumar N, Masih J, Bose SN, Varma N, et al. Thrombotic primary antiphospholipid syndrome: the profile of antibody positivity in patients from North India. Int J Rheum Dis 2014 Oct 8 (E-pub ahead of print).
29. Aboud M, Morel-Kopp MC, Ward C, Coyle L. False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant. J Thromb Haemost 2010;8:2070-3.
30. Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004;104:143-8.
31. Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2012;379:244-9.
32. Gaffo AL. Thrombosis in vasculitis. Best Pract Res Clin Rheumatol 2013;27:57-67.
33. Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus 2012;21:1412-22.
34. Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009;35:695-710.
35. Johnson NV, Khor B, Van Cott EM. Advances in laboratory testing for thrombophilia. Am J Hematol 2012;87 Suppl 1:S108-12.
36. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.